Report in English with a Dutch summary (KCE reports 45A)
Share Embed Flag
Download ePaper

Report in English with a Dutch summary (KCE reports 45A)

Report in English with a Dutch summary (KCE reports 45A) Report in English with a Dutch summary (KCE reports 45A)

kce.fgov.be
10.08.2013 Views

224 Screening for Colorectal Cancer KCE reports vol.45 121. Chikhaoui Y, Gelinas H, Joseph L, Lance J-M. Cost-minimization analysis of genetic testing versus clinical screening of at-risk relatives for familial adenomatous polyposis. International Journal of Technology Assessment in Health Care. 2002;18(1):67-80. 122. Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118(5):829-34. 123. Lindgren G, Liljegren A, Jaramillo E, Rubio C, Lindblom A. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut. 2002;50(2):228-34. 124. Annie Yu HJ, Lin KM, Ota DM, Lynch HT. Hereditary nonpolyposis colorectal cancer: preventive management. Cancer Treat Rev. 2003;29(6):461-70. 125. CRD. Current clinical selection strategies for identification of hereditary nonpolyposis colorectal cancer families are inadequate: a meta-analysis (Provisional record). Database of Abstracts of Reviews of Effectiveness. 2006;1:1. 126. Haug U, Brenner H. New stool tests for colorectal cancer screening: a systematic review focusing on performance characteristics and practicalness. International Journal of Cancer. 2005;117(2):169-76. 127. Yang SH, Chien CC, Chen CW, Li SY, Huang CJ. Potential of faecal RNA in diagnosing colorectal cancer. Cancer Letters. 2005;226(1):55-63. 128. Engel C, Forberg J, Holinski-Feder E, Pagenstecher C, Plaschke J, Kloor M, et al. Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. International Journal of Cancer. 2006;118(1):115-22. 129. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol. 2006;101(2):385-98. 130. Stern HS, Viertelhausen S, Hunter AG, O'Rourke K, Cappelli M, Perras H, et al. APC I1307K increases risk of transition from polyp to colorectal carcinoma in Ashkenazi Jews. Gastroenterology. 2001;120(2):392-400. 131. Jenkins MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, et al. After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer families. Int J Cancer. 2002;102(2):166-71. 132. Croitoru ME, Cleary SP, Di Nicola N, Manno M, Selander T, Aronson M, et al. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. Journal of the National Cancer Institute. 2004;96(21):1631-4. 133. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Cancer Epidemiology, Biomarkers & Prevention. 2005;14(4):863-70. 134. Liden A, Berglund G, Hansson MG, Rosenquist R, Sjoden PO, Nordin K. Genetic counselling for cancer and risk perception. Acta Oncologica. 2003;42(7):726-34. 135. Eaden J. Review article: colorectal carcinoma and inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 2004;4:24-30. 136. Eisinger F, Giordanella JP, Brigand A, Didelot R, Jacques D, Schenowitz G, et al. Cancer prone persons. A randomized screening trial based on colonoscopy: background, design and recruitment. Fam Cancer. 2001;1(3-4):175-9. 137. Askling J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology. 2001;120(6):1356-62. 138. Schoenfeld P, Shad J, Ormseth E, Coyle W, Cash B, Butler J, et al. Predictive value of diminutive colonic adenoma trial: the PREDICT trial. Clin Gastroenterol Hepatol. 2003;1(3):195-201. 139. Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology. 2006;130(7):1995-2000.

KCE reports vol.45 Screening for Colorectal Cancer 225 140. Benhamiche-Bouvier AM, Lejeune C, Jouve JL, Manfredi S, Bonithon-Kopp C, Faivre J. Family history and risk of colorectal cancer: implications for screening programmes. J Med Screen. 2000;7(3):136-40. 141. Rex D. Should we colonoscope women with gynecologic cancer? American Journal of Gastroenterology. 2000;95(3):812-3. 142. Hemminki K, Li X, Dong C. Second primary cancers after sporadic and familial colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention. 2001;10(7):793-8. 143. Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut. 2004;53(9):1322-8. 144. Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA. 2005;293(16):1979-85. 145. Pinol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X, et al. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005;293(16):1986-94. 146. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001;96(10):2992-3003. 147. AHRQ. Screening for Colorectal Cancer In Adults - Systematic Evidence Review. AHRQ Publication No. 02-S003. 2002. 148. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42(2):216-27. 149. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112(2):594-642. 150. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med. 1996;334(2):82-7. 151. Weinberg DS, Newschaffer CJ, Topham A. Risk for colorectal cancer after gynecologic cancer. Annals of Internal Medicine. 1999;131(3):189-93. 152. Eisen GM, Sandler RS. Are women with breast cancer more likely to develop colorectal cancer? Critical review and meta-analysis. J Clin Gastroenterol. 1994;19(1):57-63. 153. Kewenter J, Haglind E, Smith L. Value of a risk questionnaire in screening for colorectal neoplasm. Br J Surg. 1989;76(3):280-3. 154. Ruo L, Cellini C, La-Calle JP, Jr., Murray M, Thaler HT, Quan SH, et al. Limitations of family cancer history assessment at initial surgical consultation. Diseases of the Colon & Rectum. 2001;44(1):98-103; discussion -4. 155. Bradshaw N, Holloway S, Penman I, Dunlop MG, Porteous ME. Colonoscopy surveillance of individuals at risk of familial colorectal cancer. Gut. 2003;52(12):1748- 51. 156. Mitchell RJ, Brewster D, Campbell H, Porteous ME, Wyllie AH, Bird CC, et al. Accuracy of reporting of family history of colorectal cancer. Gut. 2004;53(2):291-5. 157. Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). New England Journal of Medicine. 2005;352(18):1851-60. 158. Hurlstone DP, Karajeh M, Cross SS, McAlindon ME, Brown S, Hunter MD, et al. The role of high-magnification-chromoscopic colonoscopy in hereditary nonpolyposis colorectal cancer screening: a prospective "back-to-back" endoscopic study. American Journal of Gastroenterology. 2005;100(10):2167-73.

224 Screen<strong>in</strong>g for Colorectal Cancer <strong>KCE</strong> <strong>reports</strong> vol.45<br />

121. Chikhaoui Y, Gel<strong>in</strong>as H, Joseph L, Lance J-M. Cost-m<strong>in</strong>imization analysis of genetic<br />

test<strong>in</strong>g versus cl<strong>in</strong>ical screen<strong>in</strong>g of at-risk relatives for familial adenomatous<br />

polyposis. International Journal of Technology Assessment <strong>in</strong> Health Care.<br />

2002;18(1):67-80.<br />

122. Jarv<strong>in</strong>en HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al.<br />

Controlled 15-year trial on screen<strong>in</strong>g for colorectal cancer <strong>in</strong> families <strong>with</strong><br />

hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118(5):829-34.<br />

123. L<strong>in</strong>dgren G, Liljegren A, Jaramillo E, Rubio C, L<strong>in</strong>dblom A. Adenoma prevalence and<br />

cancer risk <strong>in</strong> familial non-polyposis colorectal cancer. Gut. 2002;50(2):228-34.<br />

124. Annie Yu HJ, L<strong>in</strong> KM, Ota DM, Lynch HT. Hereditary nonpolyposis colorectal<br />

cancer: preventive management. Cancer Treat Rev. 2003;29(6):461-70.<br />

125. CRD. Current cl<strong>in</strong>ical selection strategies for identification of hereditary nonpolyposis<br />

colorectal cancer families are <strong>in</strong>adequate: a meta-analysis (Provisional<br />

record). Database of Abstracts of Reviews of Effectiveness. 2006;1:1.<br />

126. Haug U, Brenner H. New stool tests for colorectal cancer screen<strong>in</strong>g: a systematic<br />

review focus<strong>in</strong>g on performance characteristics and practicalness. International<br />

Journal of Cancer. 2005;117(2):169-76.<br />

127. Yang SH, Chien CC, Chen CW, Li SY, Huang CJ. Potential of faecal RNA <strong>in</strong><br />

diagnos<strong>in</strong>g colorectal cancer. Cancer Letters. 2005;226(1):55-63.<br />

128. Engel C, Forberg J, Hol<strong>in</strong>ski-Feder E, Pagenstecher C, Plaschke J, Kloor M, et al.<br />

Novel strategy for optimal sequential application of cl<strong>in</strong>ical criteria,<br />

immunohistochemistry and microsatellite analysis <strong>in</strong> the diagnosis of hereditary<br />

nonpolyposis colorectal cancer. International Journal of Cancer. 2006;118(1):115-22.<br />

129. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol.<br />

2006;101(2):385-98.<br />

130. Stern HS, Viertelhausen S, Hunter AG, O'Rourke K, Cappelli M, Perras H, et al. APC<br />

I1307K <strong>in</strong>creases risk of transition from polyp to colorectal carc<strong>in</strong>oma <strong>in</strong> Ashkenazi<br />

Jews. Gastroenterology. 2001;120(2):392-400.<br />

131. Jenk<strong>in</strong>s MA, Baglietto L, Dite GS, Jolley DJ, Southey MC, Whitty J, et al. After<br />

hMSH2 and hMLH1--what next? Analysis of three-generational, population-based,<br />

early-onset colorectal cancer families. Int J Cancer. 2002;102(2):166-71.<br />

132. Croitoru ME, Cleary SP, Di Nicola N, Manno M, Selander T, Aronson M, et al.<br />

Association between biallelic and monoallelic germl<strong>in</strong>e MYH gene mutations and<br />

colorectal cancer risk. Journal of the National Cancer Institute. 2004;96(21):1631-4.<br />

133. Tranah GJ, Giovannucci E, Ma J, Fuchs C, Hunter DJ. APC Asp1822Val and<br />

Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma. Cancer<br />

Epidemiology, Biomarkers & Prevention. 2005;14(4):863-70.<br />

134. Liden A, Berglund G, Hansson MG, Rosenquist R, Sjoden PO, Nord<strong>in</strong> K. Genetic<br />

counsell<strong>in</strong>g for cancer and risk perception. Acta Oncologica. 2003;42(7):726-34.<br />

135. Eaden J. Review article: colorectal carc<strong>in</strong>oma and <strong>in</strong>flammatory bowel disease.<br />

Alimentary Pharmacology & Therapeutics. 2004;4:24-30.<br />

136. Eis<strong>in</strong>ger F, Giordanella JP, Brigand A, Didelot R, Jacques D, Schenowitz G, et al.<br />

Cancer prone persons. A randomized screen<strong>in</strong>g trial based on colonoscopy:<br />

background, design and recruitment. Fam Cancer. 2001;1(3-4):175-9.<br />

137. Askl<strong>in</strong>g J, Dickman PW, Karlen P, Brostrom O, Lapidus A, Lofberg R, et al. Family<br />

history as a risk factor for colorectal cancer <strong>in</strong> <strong>in</strong>flammatory bowel disease.<br />

Gastroenterology. 2001;120(6):1356-62.<br />

138. Schoenfeld P, Shad J, Ormseth E, Coyle W, Cash B, Butler J, et al. Predictive value of<br />

dim<strong>in</strong>utive colonic adenoma trial: the PREDICT trial. Cl<strong>in</strong> Gastroenterol Hepatol.<br />

2003;1(3):195-201.<br />

139. Dove-Edw<strong>in</strong> I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, et al. Prospective<br />

results of surveillance colonoscopy <strong>in</strong> dom<strong>in</strong>ant familial colorectal cancer <strong>with</strong> and<br />

<strong>with</strong>out Lynch syndrome. Gastroenterology. 2006;130(7):1995-2000.

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!